ATHENS, Greece — Although melanoma occurs much more frequently in people with lighter complexions, people with darker skin are also at risk, according to experts who spoke at the 11th World Congress of Melanoma and 21st EADO Congress 2025 on the challenges of diagnosing the condition in patients with dark skin.
2025
Do Low-Grade Toxicities Affect Melanoma Treatment Success?
Among patients with stage III melanoma who received adjuvant pembrolizumab, more than 50% experienced low-grade toxicities. The results of such toxicities included patients discontinuing treatment, being hospitalized, and needing immunosuppression.
Autoimmune Disease Patients Face Significantly Higher Skin Cancer Risk
Patients with a rare disease called mucous membrane pemphigoid are at risk of developing squamous cell carcinoma and basal cell carcinoma, finds a new study.
Building New Roads to a Melanoma Cure
Just a handful of years ago, malignant melanoma was a diagnosis with few treatment options. Oncologists had no obvious roadmap for this perilous disease and were forced to explore beyond targeted therapies and chemotherapy.